Bordetella
pertussis |
|
|
Bordetella pertussis (B. Pertussis) is a small,
coccobacillus. Coccobacillus are rod-shaped bacteria. Cocco comes from "cocci"
meaning spherical shaped and bacillus comes from "bacilli" meaning
elongated. B. pertussis, like most pathogenic bacteria, is
Gram-negative. Gram-negative bacteria contain a lipopolysaccharide (LPS)
layer. The LPS triggers the body's immune response. The immune system
senses a cytokine reaction, which is toxic to the body. Because of this,
the body initiates the inflammation of the tissues and blood vessels.
B. pertussis is non-motile, meaning it doesn't move.
|
Classification |
Domain: Prokaryotes
Kingdom:Bacteria
Phylum: Proteobacteria
Class:Betaproteobacteria
Order:Burkholderiaceae
Family:Alcaligenaceae
Genus: Bordetella
Species: B. pertussis |
|
There are currently eight species in the Bordetella
genus. Three species in this genus are known to be pathogenic to humans.
B. pertussis and B. parapertussis are very similar species.
Both species cause pertussis (whooping cough) in humans and are
separated merely by the toxins they release during infection.
B. parapertussis releases toxins that seem to cause a milder form of
pertussis (whooping cough).
B. bronchiseptica causes respiratory disease in various mammals and
occasionally in humans. The species is further separated from
B. pertussis and B. parapertussis by being motile. The human
pathology of the remaining five species is relatively unknown. B.
avium and B. hinzii,
are known to cause respiratory disease in poultry. |
|
Habitat |
B. pertussis colonize the cilia of the mammalian respiratory
epithelium. The epithelium is a tissue composed of a layer of cells. The
main purpose of the respiratory epithelium is to moisten and protect the
airways. It was originally thought that B. pertussis did not
invade the tissues. Though, recent research has shown that tissue
invasion may occur. After B. pertussis has invaded the
respiratory tract, the bacteria use several toxins to bind and destroy
the epithelial cells. It begins by using hemoagglutinin, a protein,
which aids the bacteria in binding to the cilia surface. Next, the
pertussis toxin, an exotoxin, enters the cells and activates the
production of cAMP. This molecule is one of the messengers in cell
protein synthesis regulation. Finally, B. pertussis releases the
tracheal cytotoxin, which causes the destruction of the cilia in the
epithelial cells. |
|
Pertussis
(Whooping Cough) |
Pertussis, or whooping cough, is a highly contagious respiratory
tract infection. It affects an estimated 39 million people each year,
and kills 297,000 people worldwide.
Areas of infection |
|
- Mouth
- Nose
- Throat |
|
Risk groups |
|
- Unvaccinated children (especially infants)
- Adolescents whose immunity has waned
- Adults whose immunity has waned |
|
Transmission |
|
- Direct contact with droplets from
coughing or sneezing by an infected person
- Can continue to transmit the bacteria three weeks after
coughing spells have stopped
- Can be carried by individuals who are immune and transmitted
to those who are not
- Usual epidemic cycles in most countries is every two to five
years |
|
|
Symptoms |
|
- Incubation period is five to ten days
- Infected person usually first shows cold symptoms
(i.e. runny nose,
sneezing, fever, and mild cough)
- The cough worsens and comes in bursts
- At the end of the cough, the infected person takes in air with
a high-pitched "whoop" from which the infection gets its name |
|
Complications |
|
- Can cause death in infants
- Convulsions
- Dehydration
- Inflammation of the middle ear
- Lost of appetite
- Seizures |
|
Treatment |
|
- Antibiotic treatment, usually erythromycin
- Increased fluids
- Increased rest |
|
Prevention |
|
- Immunization with pertussis vaccine |
|
|
References |
- Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds.
(2007). Epidemiology and prevention of vaccine preventable
disease. (10th Ed., pp. #81-100). Atlanta, Georgia: Center
for Disease |
- Centers for Disease Control (CDC) and Prevention;
Department of Health and Human Services. Pertussis. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/pertussis_t.htm |
- Cherry, J.D. (1999). Epidemiological, clinical, and
laboratory aspects of pertussis in adults. Clinical
Infectious Disease, 28, S112-117. |
- Farizo, K. M., Cochi, S. L., Zell, E. R. et al.
(1992). Epidemiological features of pertussis in the United
States. Clinical Infectious Diseases, 14, 708-719. |
- Frits R. Mooi, Inge H. M. van Loo, and Audrey King.
National Institute for Public Health and the Environment
(RIVM) Bilthoven, The Netherlands. http://www.cdc.gov/ncidod/eid/vol7no3_supp/images/mooi1b.gif |
- Ivanoff, B., Robertson, S. E. (1997). Pertussis: A
worldwide problem. Dev Biol Stand, 89, 3-13. |
- Kendrick, P. L. (1975). Can whooping cough be
eradicated? Journal of Infectious Diseases,132,707-712. |
- World Health Organization (WHO). Pertussis - the
disease. http://www.who.int/immunization/topics/pertussis/en/index1.html |
|
|
About |
|
Britten Wolf
Undergraduate Student
College of Science & Allied Health
University of Wisconsin - La Crosse
wolf.bri2@students.uwlax.edu
©2007 Britten Wolf. All rights reserved. |
|
|
|